Scaffold Technology Market by Product Type, by Type, Application, and End User : Global Opportunity Analysis and Industry Forecast, 2020-2027

Scaffold Technology Market by Product Type, by Type, Application, and End User : Global Opportunity Analysis and Industry Forecast, 2020-2027

  • April 2021 •
  • 238 pages •
  • Report ID: 6090170 •
  • Format: PDF
Scaffold Technology Market by Product Type (Natural Scaffold and Synthetic Scaffold), by Type (Macro-porous Scaffolds, Micro-porous Scaffolds, Nano-porous Scaffolds, Solid Scaffolds), Application (Cancer Cell Research, Stem Cell Research, Drug Discovery, Regenerative Medicine, and Others), and End User (Biotechnology & Pharmaceutical Companies, Contract Research Laboratories, and Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2020-2027

The global scaffold technology market was valued at $1,930.37 million in 2019, and is projected to reach $7,522.33 million by 2027, registering a CAGR of 18.3% from 2019 to 2027.

Cell culture is a significant tool in biological research. It is mainly of two types, two-dimensional (2D) and three-dimensional (3D). Since the advent of cell culture techniques, 2D cell cultures are mostly preferred due to their availability, ease of environmental control, cell observation, and measurement. However, growing cells in flat layers on surfaces do not precisely model the in-vivo state. As compared to 2D, 3D cell culture permits the biological cells to grow and interact with their surroundings in all three dimensions. Scaffolds are 3D porous and fibrous biomaterials that promote cell interaction, viability, and extracellular matrix (ECM) deposition with minimum inflammation and toxicity.

The growth of the global scaffold technology market is majorly driven by rise in demand for body reconstruction procedures and tissue engineering, increase in usage of biomaterials, and growth of technological advancement of scaffold technology. However, high costs associated with implementation and emergence of scaffold-free technology for cell culturing are expected to hamper the growth of the market. On the contrary, increase in expenditure on R&D by governments in developing countries has high growth potential in these countries.

The scaffold technology market is segmented on the basis of product type, type, application, end user, and region. Based on product type, the scaffold technology market is divided into natural scaffold and synthetic scaffold. On the basis of type, it is divided into macro-porous scaffolds, micro-porous scaffolds, nano-porous scaffolds, and solid scaffolds. By application, it is fragmented into cancer cell research, stem cell research, drug discovery, regenerative medicine, and others. By end user, it is classified into biotechnology & pharmaceutical companies, contract research laboratories, and academic institutes. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
- This report entails a detailed quantitative analysis along with the current global scaffold technology market trends from 2020 to 2027 to identify the prevailing opportunities along with the strategic assessment.
- The scaffold technology market forecast is studied from 2020 to 2027.
- The market size and estimations are based on a comprehensive analysis of key developments in the industry.
- A qualitative analysis based on innovative products facilitates strategic business planning.
- The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

KEY MARKET SEGMENTS

By Product Type
• Natural Scaffold
• Synthetic Scaffold

By Type
• Macro-porous Scaffolds
• Micro-porous Scaffolds
• Nano-porous Scaffolds
• Solid Scaffolds

By Application
• Cancer Cell Research
• Stem Cell Research
• Drug Discovery
• Regenerative Medicine

By End User
• Biotechnology & Pharmaceutical Companies
• Contract Research Laboratories
• Academic Institutes

By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o Rest of Asia-Pacific
• LAMEA
o Brazil
o South Africa
o Saudi Arabia
o Rest of LAMEA

KEY MARKET PLAYERS
• 3D Biotek LLC
• Advanced Biomatrix, Inc.
• Agilent Technologies, Inc. (Biotek)
• BioVison, Incorporated
• Corning Incorporated
• Merck KGaA (Sigmaaldrich)
• PromoCell GmbH
• Reprocell, Incorporation
• Synthecon, Incorporated
• Thermo Fisher Scientific Inc.